138 related articles for article (PubMed ID: 24584175)
1. Probucol suppresses macrophage infiltration and MMP expression in atherosclerotic plaques of WHHL rabbits.
Li S; Liang J; Niimi M; Bilal Waqar A; Kang D; Koike T; Wang Y; Shiomi M; Fan J
J Atheroscler Thromb; 2014; 21(7):648-58. PubMed ID: 24584175
[TBL] [Abstract][Full Text] [Related]
2. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
[TBL] [Abstract][Full Text] [Related]
3. Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.
Keyamura Y; Nagano C; Kohashi M; Niimi M; Nozako M; Koyama T; Yasufuku R; Imaizumi A; Itabe H; Yoshikawa T
PLoS One; 2014; 9(5):e96929. PubMed ID: 24810608
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects.
Wang Y; Bai L; Lin Y; Guan H; Zhu N; Chen Y; Li Y; Gao S; Zhao S; Fan J; Liu E
Histol Histopathol; 2014 Dec; 29(12):1593-600. PubMed ID: 25078428
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
Rajamannan NM; Subramaniam M; Springett M; Sebo TC; Niekrasz M; McConnell JP; Singh RJ; Stone NJ; Bonow RO; Spelsberg TC
Circulation; 2002 Jun; 105(22):2660-5. PubMed ID: 12045173
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
Zhou G; Ge S; Liu D; Xu G; Zhang R; Yin Q; Zhu W; Chen J; Liu X
Cardiology; 2010; 115(3):221-8. PubMed ID: 20234134
[TBL] [Abstract][Full Text] [Related]
8. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
[TBL] [Abstract][Full Text] [Related]
9. Effect of probucol on vascular remodeling due to atherosclerosis in rabbits: an intravascular ultrasound study.
Li TT; Xie Y; Guo Y; Tian HB; Zhang JN; Peng J; Zhang Y
Chin Med J (Engl); 2011 Jun; 124(12):1840-7. PubMed ID: 21740843
[TBL] [Abstract][Full Text] [Related]
10. Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits.
Liu D; Ge S; Zhou G; Xu G; Zhang R; Zhu W; Liu Z; Cheng S; Liu X
Cardiovasc Drugs Ther; 2009 Dec; 23(6):431-7. PubMed ID: 19998057
[TBL] [Abstract][Full Text] [Related]
11. Effect of minocycline on carotid atherosclerotic plaques.
Gao J; Gao X; Pan S
Neurol Res; 2013 Oct; 35(8):844-50. PubMed ID: 23676309
[TBL] [Abstract][Full Text] [Related]
12. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits.
Zhao SP; Wu ZH; Wu J; Hong SC; Deng P
J Cardiovasc Pharmacol; 2005 Aug; 46(2):185-9. PubMed ID: 16044030
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
Shiomi M; Koike T; Ito T
Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
[TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
Guo X; Wang L; Xia X; Wang P; Li X
Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
[TBL] [Abstract][Full Text] [Related]
16. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
[TBL] [Abstract][Full Text] [Related]
17. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
Bai W; Zheng X; Zhou L; Li H
Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
[TBL] [Abstract][Full Text] [Related]
19. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]